Myomo (MYO) Net Margin Growth (5y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10,781.00 |
| Jun 30, 2025 | 33,484.00 |
| Mar 31, 2025 | 40,841.00 |
| Dec 31, 2024 | 23,599.00 |
| Sep 30, 2024 | 44,912.00 |
| Jun 30, 2024 | 27,649.00 |
| Mar 31, 2024 | 30,692.00 |
| Dec 31, 2023 | 43,415.00 |
| Sep 30, 2023 | 39,518.00 |
| Jun 30, 2023 | 39,881.00 |
| Mar 31, 2023 | 67,218.00 |
| Dec 31, 2022 | 238,945.00 |
| Sep 30, 2022 | 18,639.00 |
| Jun 30, 2022 | 244,944.00 |
| Mar 31, 2022 | 936,214.00 |
| Dec 31, 2021 | 22,965.00 |
| Sep 30, 2021 | 61,050.00 |
| Jun 30, 2021 | 28,976.00 |